CNS pipeline · person
Shawn K. Singh, J.D.
President and Chief Executive Officer of Vistagen and a member of its Board. Has served as CEO since August 2009 and as President since December 2024, with over 30 years of senior leadership experience across private and public biotech, medical device, and pharmaceutical companies; previously Managing Principal of Cato BioVentures and Chief Business Officer of SciClone Pharmaceuticals.
- 1 company
Current roles
- Vistagen Therapeutics, Inc.President, Chief Executive Officer and Director · Executive2009–present
Appears with
People sharing a company with Shawn.
- Ann M. Cunningham · Vistagen Therapeutics, Inc.
- Cynthia L. Anderson · Vistagen Therapeutics, Inc.
- Elissa Cote · Vistagen Therapeutics, Inc.
- Gerard Sanacora · Vistagen Therapeutics, Inc.
- Gordon Keller · Vistagen Therapeutics, Inc.
- Joanne Curley · Vistagen Therapeutics, Inc.
- Jon S. Saxe · Vistagen Therapeutics, Inc.
- Joshua S. Prince · Vistagen Therapeutics, Inc.
- Margaret M. FitzPatrick · Vistagen Therapeutics, Inc.
- Mark Wallace · Vistagen Therapeutics, Inc.
- Mary L. Rotunno · Vistagen Therapeutics, Inc.
- Maurizio Fava · Vistagen Therapeutics, Inc.
- Michael R. Liebowitz · Vistagen Therapeutics, Inc.
- Reid G. Adler · Vistagen Therapeutics, Inc.
- Sanjay Mathew · Vistagen Therapeutics, Inc.
- Thomas Laughren · Vistagen Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.